Quinuclidine derivatives as potential antiparasitics

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 11, 2007, Pages 4049-4061

  Cammerer, Simon B ^a   Jimenez, Carmen ^b   Jones, Simon ^a   Gros, Ludovic ^c   Lorente, Silvia Orenes ^a   Rodrigues, Carlos ^d   Rodrigues, Juliany C F ^e   Caldera, Aura ^d   Perez, Luis Miguel Ruiz ^b   Da Souza, Wanderley ^e   Kaiser, Marcel ^f   Brun, Reto ^f   Urbina, Julio A ^d   Pacanowska, Dolores Gonzalez ^b   Gilbert, Ian H ^a,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 BIPHENYL 4 YL 3 HYDROXYQUINUCLIDINE; ANTIPARASITIC AGENT; E 5700; ER 119884; QUINUCLIDINE DERIVATIVE; SQUALENE SYNTHASE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ANIMAL CELL; ARTICLE; CHAGAS DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SYNTHESIS; GROWTH INHIBITION; LEISHMANIA MAJOR; LEISHMANIASIS; NONHUMAN; PARASITOSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STEROL SYNTHESIS; TRYPANOSOMA BRUCEI;

ANIMALS; ANTIPARASITIC AGENTS; CELLS, CULTURED; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; LEISHMANIA MAJOR; MOLECULAR STRUCTURE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; QUINUCLIDINES; RATS; RECOMBINANT PROTEINS; STEROLS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOSOMA BRUCEI BRUCEI;

EID: 35948991176     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00205-07     Document Type: Article

References (50)

1. Amano, Y., T. Nishinioto, R. Tozawa, E. Ishikawa, Y. Imura, and Y. Sugiyama. 2003. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia. Eur. J. Pharmacol. 466:155-161.
2. Amin, D., R. Z. Rutledge, S. N. Needle, H. F. Galczenski, K. Neuenschwander, A. C. Scotese, M. P. Maguire, R. C. Bush, D. J. Hele, G. E. Bilder, and M. H. Perrone. 1997. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase. J. Pharmacol. Exp. Ther. 281:746-752.
3. Baltz, T., D. Baltz, C. Giroud, and J. Crockett. 1985. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J. 4:1273-1277.
4. Bergstrom, J. D., M. M. Kurtz, D. J. Rew, A. M. Amend, J. D. Karkas, R. G. Bostedor, V. S. Bansal, C. Dufresne, F. L. Vanmiddlesworth, O. D. Hensens, J. M. Liesch, D. L. Zink, K. E. Wilson, J. Onishi, J. A. Milligan, G. Bills, L. Kaplan, M. N. Omstead, R. G. Jenkins, L. Huang, M. S. Meinz, L. Quinn, R. W. Burg, Y. L. Kong, S. Mochales, M. Mojena, I. Martin, F. Pelaez, M. T. Diez, and A. W. Alberts. 1993. Zaragozic acids - a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA 90:80-84.
5. Biller, S. A., K. Neuenschwander, M. M. Ponpipom, and C. D. Poulter. 1996. Squalene synthase inhibitors. Curr. Pharm. Design 2:1-40.
6. Bostedor, R. G., J. D. Karkas, B. H. Arison, V. S. Bansal, S. Vaidya, J. I. Germershausen, M. M. Kurtz, and J. D. Bergstrom. 1997. Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. J. Biol. Chem. 272:9197-9203.
7. Braga, M. V., J. A. Urbina, and W. de Souza. 2004. Effects of squalene synthase inhibitors on the growth and ultrast7ructure of Trypanosoma cruzi. Int. J. Antimicrob. Agents 24:72-78.
8. Concepcion, J. L., D. Gonzalez-Pacanowska, and J. A. Urbina. 1998. 3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: subcellular localization and kinetic properties. Arch. Biochem. Biophys. 352:114-120.
9. Contreras, L. M., J. Vivas, and J. A. Urbina. 1997. Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors. Biochem. Pharmacol. 53:697-704.
10. Coppens, I., and P. J. Courtoy. 2000. The adaptative mechanisms of Trypanosoma brucei for sterol homeostasis in its different life-cycle environments. Annu. Rev. Microbiol. 54:129-156.
11. Coppens, I., and P. J. Courtoy. 1995. Exogenous and endogenous sources of sterols in the culture-adapted procyclic trypomastigotes of Trypanosoma brucei. Mol. Biochem. Parasitol. 73:179-188.
12. Cunningham, I. 1977. New culture medium for maintenance of tsetse tissues and growth of trypanosomatids. J. Protozool. 24:325-329.
13. Desjardins, R. E., C. J. Canfield, D. Haynes, and J. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
14. Gros, L., V. M. Castillo-Acosta, C. J. Jimenez, M. Sealey-Cardona, S. Vargas, A. M. Estevez, V. Yardley, L. Rattray, S. L. Croft, L. M. Ruiz-Perez, J. A. Urbina, I. H. Gilbert, and D. Gonzalez-Pacanowska. 2006. New azasterols against Trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor action. Antimicrob. Agents Chemother. 50:2595-2601.
15. Jones, S. M., J. E. Urch, M. Kaiser, R. Brun, J. L. Harwood, C. Berry, and I. H. Gilbert. 2005. Analogues of thiolactomycin as potential antimalarial agents. J. Med. Chem. 48:5932-5941.
16. Keller, R. K. 1996. Squalene synthase inhibition alters metabolism of non-sterols in rat liver. Biochim. Biophys. Acta Lipids Lipid Metab. 1303:169-179.
17. Larralde, G., J. Vivas, and J. A. Urbina. 1988. Concentration and time-dependence of the effects of ketoconazole on growth and sterol synthesis by Trypanosoma (Schizotrypanum) cruzi epimastigotes. Acta Cientifica Venezolana 39:140-146.
18. Lazardi, K., J. A. Urbina, and W. Desouza. 1990. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 34:2097-2105.
19. Liendo, A., K. Lazardi, and J. A. Urbina. 1998. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. J. Antimicrob. Chemother. 41:197-205.
20. Liendo, A., G. Visbal, M. M. Piras, R. Piras, and J. A. Urbina. 1999. Sterol composition and biosynthesis in Tryanosoma cruzi amastigotes. Mol. Biochem. Parasitol. 104:81-91.
21. Lorente, S. O., C. J. Jimenez, L. Gros, V. Yardley, K. de Luca-Fradley, S. L. Croft, J. A. Urbina, L. M. Ruiz-Perez, D. G. Pacanowska, and I. H. Gilbert. 2005. Preparation of transition-state analogues of sterol 24-methyl transferase as potential anti-parasities. Bioorg. Med. Chem. 13:5435-5453.
22. Lorente, S. O., J. C. F. Rodrigues, C. J. Jimenez, M. Joyce-Menekse, C. Rodrigues, S. L. Croft, V. Yardley, K. de Luca-Fradley, L. M. Ruiz-Perez, J. Urbina, W. de Souza, D. G. Pacanowska, and I. H. Gilbert. 2004. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob. Agents Chemother. 48:2937-2950.
23. Magaraci, F., C. Jimenez Jimenez, C. O. Rodrigues, C. F. Rodrigues, M. Vianna Braga, V. Yardley, K. de Luca-Fradley, S. L. Croft, W. de Souza, L. M. Ruiz-Perez, J. A. Urbina, D. Gonzalez Pacanowska, and I. H. Gilbert. 2003. Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania and Trypanosoma cruzi. J. Med. Chem. 46:4714-4727.
24. Maldonado, R. A., J. Molina, G. Payares, and J. A. Urbina. 1993. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrob. Agents Chemother. 37:1353-1359.
25. Martin, M. B., W. Arnold, H. T. Heath, J. A. Urbina, and E. Oldfield. 1999. Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis. Biochem. Biophys. Res. Commun. 263:754-758.
26. Martin, M. B., J. S. Grimley, J. C. Lewis, H. T. Heath, B. N. Bailey, H. Kendrick, V. Yardley, A. Caldera, R. Lira, J. A. Urbina, S. N. J. Moreno, R. Docampo, S. L. Croft, and E. Oldfield. 2001. Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy. J. Med. Chem. 44:909-916.
27. Martin, M. B., J. M. Sanders, H. Kendrick, K. de Luca-Fradley, J. C. Lewis, J. S. Grimley, E. M. Van Brussel, J. R. Olsen, G. A. Meints, A. Burzynska, P. Kafarski, S. L. Croft, and E. Oldfield. 2002. Activity of bisphosphonates against Trypanosoma brucei rhodesiense. J. Med. Chem. 45:2904-2914.
28. Matile, H., and J. R. L. Pink. 1990. Plasmodium falciparum malaria parasite cultures and their use in immunology, p. 221-234. In I. Lefkovits and B. Pernis (ed.), Immunological methods. Academic Press, Inc., San Diego, CA.
29. Molina, J., Z. Brener, A. J. Romanha, and J. A. Urbina. 2000. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. J. Antimicrob. Chemother. 46:137-140.
30. Molina, J., O. Martins, Z. Brener, A. J. Romanha, D. Loebenberg, and J. A. Urbina. 2000. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob. Agents Chemother. 44:150-155.
31. Orenes Lorente, S., R. Gomez, C. J. Jimenez, S. Cammerer, V. Yardley, K. de Luca-Fradley, S. L. Croft, L. M. Ruiz-Perez, J. Urbina, D. Gonzalez Pacanowska, and I. H. Gilbert. 2005. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa. Bioorg. Med. Chem. 13:3519-3529.
32. Rodrigues, J. C. F., M. Attias, C. Rodriguez, J. A. Urbina, and W. de Souza. 2002. Ultrastructural and biochemical alterations induced by 22,26- azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob. Agents Chemother. 46:487-499.
33. Rodrigues, J. C. F., J. A. Urbina, and W. de Souza. 2005. Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensis. Exp. Parasitol. 111:230-238.
34. Sharma, A., P. H. Slugg, J. L. Hammett, and W. J. Jusko. 1998. Clinical pharmacokinetics and pharmacodynamics of a new squalene synthase inhibitor, BMS-188494, in healthy volunteers. J. Clin. Pharmacol. 38:1116-1121.
35. Thompson, J. F., D. E. Danley, S. Mazzalupo, P. M. Miles, M. E. Lira, and H. J. J. Harwood. 1998. Truncation of human squalene synthase yields active, crystallizable protein. Arch. Biochem. Biophys. 350:283-290.
36. Urbina, J. A., J. L. Concepcion, A. Caldera, G. Payares, C. Sanoja, T. Otomo, and H. Hiyoshi. 2004. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi. Antimicrob. Agents Chemother. 48:2379-2387.
37. Urbina, J. A., J. L. Concepcion, S. Rangel, G. Visbal, and R. Lira. 2002. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. Mol. Biochem. Parasitol. 125:35-45.
38. Urbina, J. A., K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras. 1991. Antiproliferative effects and mechanism of action of ICI-195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 35:730-735.
39. Urbina, J. A., K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras. 1988. Antiproliferative synergism of the allylamine Sf-86327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 32:1237-1242.
40. Urbina, J. A., K. Lazardi, E. Marchan, G. Visbal, T. Aguirre, M. M. Piras, R. Piras, R. A. Maldonado, G. Payares, and W. Desouza. 1993. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 37:580-591.
41. Urbina, J. A., R. Lira, G. Visbal, and J. Bartroli. 2000. In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 44:2498-2502.
42. Urbina, J. A., G. Payares, L. M. Contreras, A. Liendo, C. Sanoja, J. Molina, M. Piras, R. Piras, N. Perez, P. Wincker, and D. Loebenberg. 1998. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 42:1771-1777.
43. Urbina, J. A., G. Payares, J. Molina, C. Sanoja, A Liendo, K. Lazardi, M. M. Piras, R. Piras, N. Perez, P. Wincker, and J. F. Ryley. 1996. Cure of short- and long-term experimental Chagas' disease using D0870. Science 273:969-971.
44. Urbina, J. A., J. Vivas, K. Lazardi, J. Molina, G. Payares, M. M. Piras, and R. Piras. 1996. Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy 42:294-307.
45. Urbina, J. A., J. Vivas, H. Ramos, G. Larralde, Z. Aguilar, and L. Avilan. 1988. Alteration of lipid order profile and permeability of plasma- membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazole. Mol. Biochem. Parasitol. 30:185-195.
46. Urbina, J. A., J. Vivas, G. Visbal, and L. M. Contreras. 1995. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta(24(25))-sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol. Biochem. Parasitol. 73:199-210.
47. Vaidya, S., R. Bostedor, M. M. Kurtz, J. D. Bergstrom, and V. S. Bansal. 1998. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A. Arch. Biochem. Biophys. 355:84-92.
48. Vivas, J., J. A. Urbina, and W. deSouza. 1997. Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by delta(24(25)) sterol methyl transferase inhibitors and their combinations with ketoconazole. Int. J. Antimicrob. Agents 8:1-6.
49. Reference deleted.
50. Yardley, V., A. A. Khan, M. B. Martin, T. R. Slifer, F. G. Araujo, S. N. J. Moreno, R. Docampo, S. L. Croft, and E. Oldfield. 2002. In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii. Antimicrob. Agents Chemother. 46:929-931.